1. Home
  2. SVRN vs ADVB Comparison

SVRN vs ADVB Comparison

Compare SVRN & ADVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SVRN
  • ADVB
  • Stock Information
  • Founded
  • SVRN 2021
  • ADVB 2014
  • Country
  • SVRN Greece
  • ADVB United States
  • Employees
  • SVRN N/A
  • ADVB N/A
  • Industry
  • SVRN Marine Transportation
  • ADVB Medical Specialities
  • Sector
  • SVRN Consumer Discretionary
  • ADVB Health Care
  • Exchange
  • SVRN Nasdaq
  • ADVB Nasdaq
  • Market Cap
  • SVRN 9.1M
  • ADVB 9.7M
  • IPO Year
  • SVRN N/A
  • ADVB 2025
  • Fundamental
  • Price
  • SVRN $1.41
  • ADVB $0.44
  • Analyst Decision
  • SVRN
  • ADVB
  • Analyst Count
  • SVRN 0
  • ADVB 0
  • Target Price
  • SVRN N/A
  • ADVB N/A
  • AVG Volume (30 Days)
  • SVRN 153.3K
  • ADVB 1.7M
  • Earning Date
  • SVRN 12-19-2025
  • ADVB 11-19-2025
  • Dividend Yield
  • SVRN N/A
  • ADVB N/A
  • EPS Growth
  • SVRN N/A
  • ADVB N/A
  • EPS
  • SVRN N/A
  • ADVB N/A
  • Revenue
  • SVRN $19,435,000.00
  • ADVB N/A
  • Revenue This Year
  • SVRN N/A
  • ADVB N/A
  • Revenue Next Year
  • SVRN N/A
  • ADVB N/A
  • P/E Ratio
  • SVRN N/A
  • ADVB N/A
  • Revenue Growth
  • SVRN N/A
  • ADVB N/A
  • 52 Week Low
  • SVRN $1.07
  • ADVB $0.34
  • 52 Week High
  • SVRN $79.25
  • ADVB $4.10
  • Technical
  • Relative Strength Index (RSI)
  • SVRN N/A
  • ADVB 51.50
  • Support Level
  • SVRN N/A
  • ADVB $0.41
  • Resistance Level
  • SVRN N/A
  • ADVB $0.49
  • Average True Range (ATR)
  • SVRN 0.00
  • ADVB 0.04
  • MACD
  • SVRN 0.00
  • ADVB 0.00
  • Stochastic Oscillator
  • SVRN 0.00
  • ADVB 59.85

About ADVB Advanced Biomed Inc. Common Stock

Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.

Share on Social Networks: